surpass-cvot tirzepatide Comparison of and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics Can Dual Incretin Receptor Agonists
Description
Those experiencing financial hardship should consult their healthcare provider about alternative treatment strategies rather than rationing doses or discontinuing therapy independently
In the paper, Banks called it troubling how easy it is to obtain a prescription for weight loss drugs and worried they might exacerbate existing eating disorders or cause new cases, including of anorexia
Researchers exploring lyophilized vs liquid peptides or other formulation types should prioritize sourcing from regulated entities within their country
But the headline numbers only tell part of the story
01324-6/asset/4a54a807-9d4c-43b0-9cee-525570c8c25d/main.assets/gr2_lrg.jpg)
N Engl J Med 2024
